Patent · US Active

Additive manufacturing using recombinant collagen-containing formulation

US12115276B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2018
Grant dateOct 15, 2024
Priority date
Expiry dateFeb 1, 2040

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB33Y10/00
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Compositions containing curable recombinant human collagen, and kits comprising same, which are usable in preparing modeling material formulations for additive manufacturing (e.g., 3D bioprinting) of 3D objects are provided. Methods utilizing such modeling material formulations in additive manufacturing of 3D objects having a collagen-based material in at least a portion thereof, are also provided. The formulations feature a desired viscosity at a temperature higher than 10° C. (e.g., room temperature or 37° C.) and allow performing the additive manufacturing without cooling the system or a part thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.